These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 23519485)
1. Expression of MSP58 in hepatocellular carcinoma. Zhong M; Zhang X; Li B; Chen CS; Ji GL; Li SX; Bi DQ; Zhao QC; Shi H Med Oncol; 2013 Jun; 30(2):539. PubMed ID: 23519485 [TBL] [Abstract][Full Text] [Related]
2. Expression of MSP58 in human colorectal cancer and its correlation with prognosis. Shi H; Li SJ; Zhang B; Liu HL; Chen CS Med Oncol; 2012 Dec; 29(5):3136-42. PubMed ID: 22773039 [TBL] [Abstract][Full Text] [Related]
3. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of the 58-kD microspherule protein (MSP58) is correlated with poor prognosis in glioma patients. Lin W; Li XM; Zhang J; Huang Y; Wang J; Zhang J; Jiang XF; Fei Z Med Oncol; 2013 Dec; 30(4):677. PubMed ID: 23996240 [TBL] [Abstract][Full Text] [Related]
5. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
6. High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma. Zhang Y; Tan YF; Jiang C; Zhang K; Zha TZ; Zhang M Pathol Oncol Res; 2013 Jan; 19(1):79-88. PubMed ID: 22965687 [TBL] [Abstract][Full Text] [Related]
7. Increased Expression of 58-kDa Microspherule Protein (MSP58) in Human Gastric Cancer Promotes Cell Proliferation and Correlates with Poor Patient Survival. Cui J; Xi H; Cai A; Ma L; Bian S; Zhang K; Wei B; Chen L Clin Lab; 2016; 62(6):993-1001. PubMed ID: 27468560 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma. Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM; Teng F Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588 [TBL] [Abstract][Full Text] [Related]
10. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma. Li B; Shao Q; Ji D; Li F; Guo X; Chen G Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637 [TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma. Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B). Hu J; Duan B; Jiang W; Fu S; Gao H; Lu L Cancer Med; 2019 Jun; 8(6):3152-3166. PubMed ID: 30972979 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
14. Involvement of hepatopoietin Cn in the development of human hepatocellular carcinoma. Zhu BD; Li XL; Liu Y; Chang J; Liu Y; Zhang DD; Wang Q; Ren J; Cui CP Clin Exp Metastasis; 2010 Dec; 27(8):571-80. PubMed ID: 20683644 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma. Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263 [TBL] [Abstract][Full Text] [Related]
16. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma. Liu X; Ou H; Xiang L; Li X; Huang Y; Yang D Oncotarget; 2017 Feb; 8(6):10510-10522. PubMed ID: 28060737 [TBL] [Abstract][Full Text] [Related]
17. [Elevated expression of CLOCK is associated with poor prognosis in hepatocellular carcinoma]. Li B; Yang X; Li J; Yang Y; Yan Z; Zhang H; Mu J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Feb; 34(2):163-168. PubMed ID: 29673458 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma. Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052 [TBL] [Abstract][Full Text] [Related]
19. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
20. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]